Home » Novartis Drug for Smoker’s Cough Boosts Lung Function in Study
Novartis Drug for Smoker’s Cough Boosts Lung Function in Study
Novartis’s experimental drug for smoker’s cough helped patients in a late-stage trial, and was at least as good as a treatment sold by Boehringer Ingelheim and Pfizer.
Businessweek
Businessweek
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May